AZD2066

DB17078InvestigationalSmall molecule

AZD2066: Overview.

Mechanism: Pharmacologically active on Metabotropic glutamate receptor 5
Curator reviewed
Formula / weight: C₁₉H₁₆ClN₅O₂ · 381.82 g/mol (avg)
Also known as: Pyridine, 4-(5-((1r)-1-(5-(3-chlorophenyl)-3-isoxazolyl)ethoxy)-4-methyl-4h-1,2,4-triazol-3-yl)-
Code names: AZD-2066

Resolves to

Compound

Structure

InChIKeySXWHYTICXCLKDG-GFCCVEGCSA-NSMILESC[C@@H](OC1=NN=C(N1C)C1=CC=NC=C1)C1=NOC(=C1)C1=CC(Cl)=CC=C1

Targets

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with AZD2066, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.